Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 580

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 7
Chunk 580
---
ated by the SEC prior to us entering into such transaction;
and

●reviewing with management, the independent registered
public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence
with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial
statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting
Standards Board, the SEC or other regulatory authorities.

Compensation Committee

We have established a compensation committee of
the board of directors. The members of our compensation committee are G. Sridhar Prasad and Myron W. Shulgan. Mr. Shulgan serves as chair
of the compensation committee. We have adopted a compensation committee charter, which details the purpose and responsibility of the compensation
committee, including:

reviewing and approving on an annual basis the
corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s
performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer
based on such evaluation;

●reviewing and making recommendations to our board
of directors with respect to the compensation, and any incentive-compensation and equity-based plans that are subject to board approval
of all of our other officers;

●reviewing our executive compensation policies
and plans;

●implementing and administering our incentive
compensation equity-based remuneration plans;

●assisting management in complying with our proxy
statement and annual report disclosure requirements;

●approving all special perquisites, special cash
payments and other special compensation and benefit arrangements for our officers and employees;

●producing a report on executive compensation
to be included in our annual proxy statement; and

●reviewing, evaluating and recommending changes,
if appropriate, to the remuneration for directors.

20

The charter also provides that the compensation
committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, independent legal counsel or other adviser
and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging
or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider
the independence of each such adviser, including the factors required by Nasdaq and the SEC.

We have not formally established any specific,
minimum qualifications that must be met or skills that are necessary for directors to possess